Global burden of the HIV pandemic

Lancet

Volumn 348, Issue 9020, 1996, Pages 99-106

  Quinn, Thomas C ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CULTURAL FACTOR; DEVELOPING COUNTRY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIGRATION; POPULATION DENSITY; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; UNEMPLOYMENT; URBANIZATION;

EID: 0030582188     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01029-X     Document Type: Review

References (50)

1. 1 Global Programme on AIDS. The current global situation of the HIV-AIDS pandemic. Geneva: World Health Organization, July 3, 1995.
2. 2 World Health Organization. AIDS-global data. Wkly Epidemiol Rec 1995; 70: 353-55.
3. 3 Nzilambi N, De Cock KM, Forthal DN, et al. The prevalence of infection with human immunodeficiency virus over a 10-year period in rural Zaire. N Engl J Med 1988; 318: 276-79.
4. 4 Decosas J, Kane F, Anarfi JK, Sodji KDR, Wagner HU. Migration and AIDS. Lancet 1995; 346: 826-28.
5. 5 Quinn TC. Population migration and the spread of types 1 and 2 human immunodeficiency viruses. Proc Natl Acad Sci USA 1994; 91: 2407-14.
6. 6 Nunn AJ, Wagner H-U, Kamali A, Kengeya-Kayondo JF, Mulder DW. Migration and HIV-1 seroprevalence in a rural Ugandan population. AIDS 1995; 9: 503-06.
7. 7 Mann J, Tarantola D. The state of the HIV/AIDS pandemic. In: Mann J, Tarantola D, eds. AIDS in the world, vol II. London: Oxford University Press (in press).
8. 8 Kaldor JM, Sittitrai W, John TJ, Kitamura T. The emerging epidemic of HIV infection and AIDS in Asia and the Pacific. AIDS 1994; 8 (suppl 2): S165-72.
9. 9 The World Bank World Develpment Report 1993: Investing in health. London: Oxford University Press, 1993.
10. 10 Mulder DW, Nunn AJ, Kamali A, Nakiyingi J, Wagner HU, Kengeya-Kayondo JF. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 1994; 343: 1021-23.
11. 11 Sewankambo NK, Wawer MJ, Gray RH, et al. Demographic impact of HIV infection in rural Rakai district, Uganda: results of a population-based cohort study. AIDS 1994; 8: 1707-13.
12. 12 Chin HJ. Current and future dimensions of the HIV/AIDS pandemic in women and children. Lancet 1990; 336: 221-24.
13. 13 Myers G, Korber B, Wain-Hobson S, Jeang K-T, Henderson LE, Pavlakis GN. Human retroviruses and AIDS 1995. Los Alamos, New Mexico: Los Alamos National Laboratory, 1995.
14. 14 D'Aquila RT. Human immunodeficiency virus type 2: human biology of the other AIDS virus. In: Remington JS, Swartz, MN, eds. Current clinical topics in infectious diseases. Cambridge: Blackwell Science, 1996: 84-101.
15. 15 Weniger BG, Takebe Y, Ou C-Y, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8 (suppl 2): S13-28.
16. 16 Quinn TC, Fauci AS. The changing demography of AIDS: emergence of heterosexual transmission. In: Isselbacher KJ, Braunwald E, Wilson JD, et al, eds. Harrison's principles of internal medicine, supplement 9. New York: McGraw Hill, 1994: 1-9.
17. 17 Haverkos HW, Quinn TC. The third wave: HIV infection among heterosexuals in the United States and Europe. Int J STD AIDS 1995; 6: 227-32.
18. 18 Wheeler VW, Radcliffe KW. HIV infection in the Caribbean. Int J STD AIDS 1994; 5: 79-89.
19. 19 Laga M, Diallo MO, Buve A. Inter-relationship of sexually transmitted diseases and HIV: where are we now? AIDS 1994; 8 (suppl 1): S119-24.
20. 20 World Health Organization. An overview of selected curable sexually transmitted diseases. Geneva: WHO Global Programme on AIDS, 1995.
21. 21 Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344: 246-48.
22. 22 Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994; 344: 243-45.
23. 23 Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-36.
24. 24 Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995; 333: 298-302.
25. 25 The Working Group on Mother-to-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr 1995; 8: 1495-97.
26. 26 Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-88.
27. 27 Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-80.
28. 28 European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464-67.
29. 29 Des Jarlais DC, Friedman SR, Choopanya K, Vanichseni S, Ward TP. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6: 1053-68.
30. 30 Nelson KE, Vlahor D, Solomon L, Cohn S, Munoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med 1995; 155: 1305-11.
31. 31 Waters JK, Estilio MJ, Clark GL, Corrick J. Syringes and needle exchange as HIV/AIDS prevention for injection drug users. JAMA 1994; 271: 115-20.
32. 32 Cohen B, Trussell J, eds. Preventing and mitigating AIDS in sub-Saharan Africa: research and data priorities for the social and behavioral sciences. Washington DC: National Academy Press, 1996.
33. 33 Miotti PG, Dallabetta G, Ndovi E, Liomba G, Saah AJ, Chiphangwi J. HIV-1 and pregnant women: associated factors, prevalence, estimate of incidence and role in fetal wastage in central Africa. AIDS 1990; 4: 733-36.
34. 34 US Bureau of Census. HIV/AIDS in Africa. Washington, DC: US Bureau of Census, 1995: research note no 20.
35. 35 Dada AJ, Oyewole F, Onofowokan R, et al. Demographic characteristics of retroviral infections (HIV-1, HIV-2 and BTLV-I) among female prostitutes in Lagos, Nigeria. J Acquir Immune Defic Syndr 1993; 269: 2853-59.
36. 36 Swanevelder R. Fifth national HIV survey of women attending antenatal clinics, South Africa, October/November 1994. In: Kustner H, ed. Epidemiological comments. Pretoria: Department of Health and Welfare, 1995; 22: 90-100.
37. 37 DeCock KM, Soro B, Coulibaly I-M, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581-87.
38. 38 Bollinger RC, Tripathy SP, Quinn TC. The human immunodeficiency virus epidemic in India. Medicine 1995; 74: 97-106.
39. 39 Brown T, Sittirai W, Vanichseni S, Thisyakom U. The recent epidemiology of HIV and AIDS in Thailand. AIDS 1994; 8 (suppl 2): S131-41.
40. 40 Cheng H, Zhang J, Capizzi J, Young NL, Mastro TD. Introduction of HIV-1 subtype E into Yunnan, China. Lancet 1994; 344: 953-54.
41. 41 Nelson KE, Celentano DD, Supraset S, et al. Risk factors for HIV infection among young adult men in northern Thailand. JAMA 1993; 270: 955-60.
42. 42 Brown T, Sittitrai W. The HIV/AIDS epidemic in Thailand: addressing the impact on children. In: Asia-Pacific population and policy (no 35). Honolulu: East-West Centre Program on Population, 1995.
43. 43 Rodrigues JJ, Mehendale SM, Shepherd ME, et al. The biological and behavioural risk factors for prevalent HIV infection in sexually transmitted disease clinics in India. BMJ 1995; 311: 283-86.
44. 44 Mehendale SM, Rodrigues JJ, Brookmeyer RS, et al. HIV-1 incidence and predictors of seroconversion in patients attending sexually transmitted diseases clinics in India. J Infect Dis 1995; 172: 1486-91.
45. 45 Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1995; 7: 1-39.
46. 46 CDC. Update: mortality attributable to HIV infection among persons aged 25-44 years - United States, 1994. Morbid Mortal Wkly Rep 1996; 45: 121-43.
47. 47 Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1995; 270: 1372-75.
48. 48 Davis SF, Byers RH Jr, Lindegren ML, et al. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 1995; 274: 952-55.
49. 49 Pape J, Johnson WD Jr. AIDS in Haiti: 1982-1992. Clin Infect Dis 1993; 17 (suppl 2): S341-45.
50. 50 Pokrovsky W, Eramova IY, Arzamastsev VP, Nikonova VA, Mozharova GI. Epidemiology of human immunodeficiency virus (HIV) infection in the USSR. Zhurnal Mikrobiol Epidemiol Immunol 1990; 2: 26-29.